The breakthrough is the beginning.
We partner with founders commercializing scientific and technological breakthroughs in biological platforms and applied robotics.
We invest $500K-1M and frequently lead or co-lead.
We invest from incorporation to seed stage, with more than 80% of our investments at pre-seed or earlier.
Investing in two areas: biological platforms and applied robotics.
Biological platforms encompass everything from material science to synthetic biology to AI for drug discovery. Applied robotics includes autonomy, chemical automation, swarm robotics systems, and biomanufacturing, among many others.